“…Although SCN is generally considered to be nontoxic, it was shown early to have a weak hypotensive action (Pauli, 1903;Barker, 1936) and, until the late 1950s, patients with refractory hypertension were prescribed large doses of sodium or potassium thiocyanate to be taken by mouth over long periods, sometimes for many years. Toxic effects, such as anaemia, psychosis, coma and death, occurred at plasma SCN concentrations greater than 2 0 m g d r 1 or 3450 (xmol litre" 1 (Garvin, 1939;Barker, Lindberg and Wald, 1941;Barnett, Jackson and Spaulding, 1951;Frohman and Klocke, 1963). Barker (1936), therefore, introduced the monitoring of plasma SCN concentrations during thiocyanate therapy and suggested that concentrations between 6 and 10 mg dl" 1 (1035-1725 [imol litre" 1 ) decrease arterial pressure, while significant toxicity occurred only above 15-20 m g d l " 1 (2590-3450 nmol litre" 1 ).…”